Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes

Fertility and Sterility

Volumn 92, Issue 1, 2009, Pages 96-107

  Wang, Tzu Hao ^a   Chao, An Shine ^a   Chen, Jen Kun ^a   Chao, Angel ^a   Chang, Yao Lung ^a   Cheng, Po Jen ^a   Chang, Shuenn Dyh ^a   Wang, Hsin Shih ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Amniotic fluid; aneuploidy; network analysis; trisomy

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATE; APOLIPOPROTEIN A1; METAL ION; PLACENTA PROTEIN 14; PREALBUMIN; TRANSFERRIN; TRYPSIN INHIBITOR;

AMNION FLUID; ANEUPLOIDY; ARTICLE; CHOLESTEROL METABOLISM; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HUMAN; ION TRANSPORT; KARYOTYPE; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOPHYSIOLOGY; PIGMENT DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; PROTEOMICS; SKIN PIGMENTATION; SUPERNATANT; THROMBOCYTE ANOMALY; TRISOMY 18; TRISOMY 21; WESTERN BLOTTING;

AMNIOCENTESIS; AMNIOTIC FLUID; ANEUPLOIDY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 19; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; HUMANS; KARYOTYPING; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTEINS; REFERENCE VALUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRISOMY;

EID: 67649099360     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.05.038     Document Type: Article

References (49)

1. Brace R.A. Amniotic fluid dynamics. In: Creasy R.K., and Resnik R. (Eds). Maternal-fetal medicine: principles and practice (2004), Saunders, Philadelphia 45-53
2. Keelan J.A., Blumenstein M., Helliwell R.J., Sato T.A., Marvin K.W., and Mitchell M.D. Cytokines, prostaglandins and parturition-a review. Placenta 24 (2003) S33-S46
3. Tsangaris G.T., Karamessinis P., Kolialexi A., Garbis S.D., Antsaklis A., Mavrou A., et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6 (2006) 4410-4419
4. Hughes C., Elgasim M., Layfield R., and Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review. Hum Reprod 21 (2006) 2766-2775
5. McDonald T., Sheng S., Stanley B., Chen D., Ko Y., Cole R.N., et al. Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics 5 (2006) 2392-2411
6. Linke T., Ross A.C., and Harrison E.H. Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Chromatogr A 1123 (2006) 160-169
7. Wang T.H., Chang Y.L., Peng H.H., Wang S.T., Lu H.W., Teng S.H., et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn 25 (2005) 559-566
8. Mathews T., and Verma R.S. Enhancement of amniotic fluid cell growth for genetic amniocentesis. Clin Genet 40 (1991) 190-193
9. Wu C.C., Chien K.Y., Tsang N.M., Chang K.P., Hao S.P., Tsao C.H., et al. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5 (2005) 3173-3182
10. Wang T.H., Chan Y.H., Chen C.W., Kung W.H., Lee Y.S., Wang S.T., et al. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene 25 (2006) 4857-4866
11. Wang T.H., Chang C.L., Wu H.M., Chiu Y.M., Chen C.K., and Wang H.S. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril 86 (2006) 1392-1401
12. Nikolsky Y., Ekins S., Nikolskaya T., and Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 158 (2005) 20-29
13. Tsai M.S., Hwang S.M., Chen K.D., Lee Y.S., Hsu L.W., Chang Y.J., et al. Functional network analysis on the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25 (2007) 2511-2523
14. Chao A., Wang T.H., Lee Y.S., Hong J.H., Tsai C.N., Chen C.K., et al. Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res 169 (2008) 76-86
15. Mason C.W., Swaan P.W., and Weiner C.P. Identification of interactive gene networks: a novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol 194 (2006) 1513-1523
16. Carr J.M., Trygubenko S.A., and Wales D.J. Finding pathways between distant local minima. J Chem Phys 122 (2005) 234903-234909
17. Ekins S., Bugrim A., Brovold L., Kirillov E., Nikolsky Y., Rakhmatulin E., et al. Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica 36 (2006) 877-901
18. Chen Y.C., Wang P.W., Pan T.L., Wallace C.G., and Chen C.J. Proteomic analysis of Down's syndrome patients with gout. Clin Chim Acta 369 (2006) 89-94
19. Shin J.H., Gulesserian T., Verger E., Delabar J.M., and Lubec G. Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical Region. J Proteome Res 5 (2006) 44-53
20. Fountoulakis M., Gulesserian T., and Lubec G. Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain. J Neural Transm Suppl 67 (2003) 85-93
21. Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M., and Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967 (2003) 152-160
22. Bajo M., Fruehauf J., Kim S.H., Fountoulakis M., and Lubec G. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex. Proteomics 2 (2002) 1539-1546
23. Kadota M., Nishigaki R., Wang C.C., Toda T., Shirayoshi Y., Inoue T., et al. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome. Neuroscience 129 (2004) 325-335
24. Stewart C.J., Iles R.K., and Perrett D. The analysis of human amniotic fluid using capillary electrophoresis. Electrophoresis 22 (2001) 1136-1142
25. Salo M.K., Solakivi-Jaakkola T., Kivimaki T., and Nikkari T. Plasma lipids and lipoproteins in Down's syndrome. Scand J Clin Lab Invest 39 (1979) 485-490
26. Dorner K., Gaethke A.S., Tolksdorf M., Schumann K.P., and Gustmann H. Cholesterol fractions and triglycerides in children and adults with Down's syndrome. Clin Chim Acta 142 (1984) 307-311
27. Pueschel S.M., Craig W.Y., and Haddow J.E. Lipids and lipoproteins in persons with Down's syndrome. J Intellect Disabil Res 36 (1992) 365-369
28. Jay V., Chan F.W., and Becker L.E. Dendritic arborization in the human fetus and infant with the trisomy 18 syndrome. Brain Res Dev Brain Res 54 (1990) 291-294
29. Seppala M., Taylor R.N., Koistinen H., Koistinen R., and Milgrom E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23 (2002) 401-430
30. Bartelik S. [Concentration of serum proteins in children with down syndrome]. Wiad Lek 45 (1992) 682-685
31. Dorta-Contreras A.J., Barshatzky M., Noris-Garcia E., and Serrano-Sanchez T. [Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy]. Rev Neurol 31 (2000) 801-804
32. Hodgkins P.S., Prasher V., Farrar G., Armstrong R., Sturman S., Corbett J., et al. Reduced transferrin binding in Down syndrome: a route to senile plaque formation and dementia. Neuroreport 5 (1993) 21-24
33. Uehara S., Obara Y., Obara T., Funato T., Yaegashi N., Fukaya T., et al. Trisomy 18 mosaicism associated with secondary amenorrhea: ratios of mosaicism in different samples and complications. Clin Genet 49 (1996) 91-94
34. Sybert V.P. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 103 (1994) 141S-143S
35. Lam W.W., Kirk J., Manning N., Reardon W., Kelley R.I., and Fitzpatrick D. Decreased cholesterol synthesis as a possible aetiological factor in malformations of Trisomy 18. Eur J Med Genet 49 (2006) 195-199
36. Makrydimas G., Plachouras N., Thilaganathan B., and Nicolaides K.H. Abnormal immunological development in fetuses with trisomy 18. Prenat Diagn 14 (1994) 239-241
37. Zizka Z., Calda P., Fait T., Haakova L., Kvasnicka J., and Viskova H. Prenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndrome. Fetal Diagn Ther 21 (2006) 510-514
38. Thilaganathan B., Meher-Homji N.J., and Nicolaides K.H. Maternal platelet size as a marker for fetal trisomies 18 and 13. Prenat Diagn 15 (1995) 605-608
39. Hohlfeld P., Forestier F., Kaplan C., Tissot J.D., and Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood 84 (1994) 1851-1856
40. Freson K., Hashimoto H., Thys C., Wittevrongel C., Danloy S., Morita Y., et al. The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest 113 (2004) 905-912
41. Bocconi L., Nava S., Fogliani R., and Nicolini U. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol 176 (1997) 540-543
42. Diomede L., Salmona M., Albani D., Bianchi M., Bruno A., Salmona S., et al. Alteration of SREBP activation in liver of trisomy 21 fetuses. Biochem Biophys Res Commun 260 (1999) 499-503
43. Tansley G.H., Burgess B.L., Bryan M.T., Su Y., Hirsch-Reinshagen V., Pearce J., et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein. J Lipid Res 48 (2007) 1022-1034
44. Anneren G., and Gebre-Medhin M. Trace elements and transport proteins in serum of children with Down syndrome and of healthy siblings living in the same environment. Hum Nutr Clin Nutr 41 (1987) 291-299
45. Elovaara I., Maury C.P., and Palo J. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome. Acta Neurol Scand 74 (1986) 245-250
46. Farrar G., Altmann P., Welch S., Wychrij O., Ghose B., Lejeune J., et al. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Lancet 335 (1990) 747-750
47. Elovaara I. Proteins in serum and cerebrospinal fluid in demented patients with Down's syndrome. Acta Neurol Scand 69 (1984) 302-305
48. Chang K.T., and Min K.T. Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function. Nat Neurosci 8 (2005) 1577-1585
49. Lee S.H., Lee S., Jun H.S., Jeong H.J., Cha W.T., Cho Y.S., et al. Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome. Mol Cells 15 (2003) 181-185